NORD Holding acquires majority stake in hg medical
hg medical, an implant manufacturer for orthopaedic surgery, has a new majority shareholder in NORD Holding. CEO Johannes Hagenmeyer remains in his position and continues to hold a stake in the company. COO Craig Bluett is appointed as a further managing director and invests in the company alongside other executives.
NORD Holding acquires the majority shareholding in hg medical from hg Darco Group LLC and Johannes Hagenmeyer, who manages the company. The transaction includes the two companies hg medical GmbH in Germany and hg medical LLC in the USA.
"We are very pleased that with the investment in hg medical, we are able to continue our investment strategy in the healthcare sector. This will enable us to participate in the strong market growth in orthopaedic implants in the long term and to actively support the management team in the coming years", says Ronald Grott, member of the management board at NORD Holding.
hg medical CEO Johannes Hagenmeyer: "It was important for us to find a responsible investment partner who can accompany our growth strategy and continue to support it with his own ideas. In NORD Holding we have found an entrepreneurial partner who brings a wealth of experience and operates on an equal footing".
On the part of NORD Holding, the transaction was managed by Ronald Grott, André Seidel, David Wössner and Konstantin Wilckens.
hg medical is a vertically integrated contract manufacturer for orthopedic implants. Its customers are primarily large medical technology companies, which are supported by hg medical in the technical implementation of product innovations, development services and individual customer solutions. The focus is on technically demanding and complex implants.
The company currently employs 143 people at two locations in Raisting, Bavaria (D) and Huntington, West Virigina (USA).
For further information, see: www.hg-medical.de
With a 50-year history and assets under management of € 2.5 billion NORD Holding is one of the leading private equity asset management companies in Germany. The focus is on the direct investment and fund of funds investment divisions.
The focus of direct business is on structuring and financing corporate succession models, the takeover of group divisions/subsidiaries and expansion financing for medium-sized companies. In contrast to most other financial investors who only manage funds for a limited period NORD Holding acts as a so-called "evergreen fund" with no time limit and invests from its own balance sheet. At present the company is invested in more than 15 companies in Germany and other German-speaking countries.
The Fund Investments division targets the small-cap segment of the European private equity market and focuses on primary, secondary and co-investments. NORD Holding concentrates strongly on buyout managers newly established on the market, operational investment strategies and also regularly acts as an anchor investor.